Standardized and quality-assured predictive PD-L1 testing in the upper gastrointestinal tract

Keyphrases

• Programmed Death-ligand 1 (PD-L1) 100%
• Upper Gastrointestinal Tract 100%
• Immuno 66%
• Immunohistochemical Analysis 33%
• Clinical Practice 33%
• Germany 33%
• Predictive Marker 33%
• Pathologist 33%
• European Union 33%
• High Heterogeneity 33%
• Oncologic 33%
• Stomach 33%
• Carcinoma 33%
• Treatment Decisions 33%
• Pathological Findings 33%
• Clinical Diagnostics 33%
• Material Quality 33%
• Treatment Control 33%
• Treatment Stratification 33%
• Interdisciplinary Group 33%
• Oncological Treatment 33%
• Gastroesophageal Junction 33%
• Tissue-based 33%
• Esophagus Cancer 33%
• Structured Reporting 33%
• PD-1 Inhibitor 33%
• Diagnostic Work 33%
• Treatment Indication 33%

Medicine and Dentistry

• Upper Digestive Tract 100%
• Programmed Cell Death 100%
• Immunoglobulin 66%
• Biological Marker 33%
• Diagnosis 33%
• Cancer 33%
• Predictive Marker 33%
• Pathologist 33%
• Cancer Therapy 33%
• Esophagus 33%
• Carcinoma 33%
• Gastroesophageal Junction 33%
• Treatment Indication 33%